Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof

Details for Australian Patent Application No. 2002258664 (hide)

International Classifications

Event Publications

13 March 2003 Application Open to Public Inspection

Published as AU-B-2002258664

17 July 2003 Amendment Made

The nature of the amendment is: Add co-inventors Pemmaraju Narasimha Rao and Carmie Kirk Acosta

3 June 2004 Corrigenda

Amendments, Section 104 - Amendments Made Under the name The Government of the United States of America (Department of Health and Human Services), application No. 2002258664, correct the name to read The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services

21 April 2005 Application Accepted

Published as AU-B-2002258664

7 July 2005 Amendment Made

The nature of the amendment is: Amend the invention title to read Methods of making, using and pharmaceutical formulations comprising 7alpha, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17-esters thereof 2002258664 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services The nature of the amendment is: Amend the priority details to read PCT/US01/10293 30 Mar 2001 US, 2001249661 30 Mar 2001 AU 2002301307 Denso Corporation The nature

18 August 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.